Although the number of episodes of hypoglycemia was comparable between pen and syringe-vial groups, insulin pen users reported less pain during injection, fewer incidents of bruising at injection sites, fewer hypoglycemic episodes, and fewer occasions of accidental breaking of insulin devices, making the pen safer to use. This evidence concerns the gene INS and Hypoglycemia.